Introducing 4-Bromo-2-Fluorobenzylamine: A Manufacturer’s Perspective

Understanding 4-Bromo-2-Fluorobenzylamine

Over the years, we’ve seen the way niche amine compounds shape research and industry applications, especially those used in pharmaceutical and agrochemical development. 4-Bromo-2-Fluorobenzylamine (sometimes referenced by its CAS number 861686-48-6) stands on its own in this landscape, having carved its niche thanks to its unique molecular structure. Crafted through careful stepwise synthesis and strict quality management, this compound features a bromine and fluorine atom attached to a benzylamine scaffold, a configuration that opens novel chemical pathways and reactivity profiles compared to standard benzylamine derivatives.

Specifications Rooted in Experience

Drawing from our daily work at the reactor and purification lines, each batch of 4-Bromo-2-Fluorobenzylamine follows precise control standards. Our material consistently presents as a white to off-white crystalline solid. Purity typically exceeds 98% by HPLC, which we verify in every lot. Trace impurities, particularly starting material residues, require vigilant monitoring—these can introduce unwanted by-products during downstream syntheses. Over the years, we’ve fine-tuned our synthesis to limit bromide and fluoride substitution side products, enhancing yield without sacrificing purity. Moisture sensitivity also demands thoughtful packaging; we use triple-seal moisture barriers and inert-gas headspace to keep the amine functional group intact during storage and transit.

What Sets This Molecule Apart

A handful of features make 4-Bromo-2-Fluorobenzylamine a preferred choice in research settings. Addition of fluorine at the ortho position relative to the amine group generates marked changes to both reactivity and metabolic stability. Fluorine alters electron density, impacting both nucleophilicity and the pathway selectivity in C-N bond formation reactions. For those in medicinal chemistry, such subtle electronegative tweaks shift the way target molecules interact with enzymes or receptors. The bromo group performs briskly in cross-coupling reactions, such as Suzuki or Buchwald-Hartwig, a process we’ve supported both in kilo-lab and pilot plant scales.

Comparing it to its cousin, plain benzylamine, there’s a distinct difference in performance. The presence of both bromine and fluorine unlocks possibilities in stepwise functionalization—reacting selectively at one site without triggering unwanted transformations at the other. That translates into fewer purification cycles down the line. Some customers who previously relied on 4-bromobenzylamine or 2-fluorobenzylamine now point to smoother progressions through their multi-step syntheses after switching to this dual-substituted variant.

Consistent Quality and Safety from Our Factory

Our experience drives every decision on the factory floor. Raw material sourcing gets as much attention as the high-pressure reactors themselves. We’ve forged close relationships with upstream halogen and amine suppliers, allowing us to batch-test for contaminants and guarantee a traceable supply chain. Lab personnel run each shipment through gas and liquid chromatography, combined with mass spectrometry when needed, to check for low-level chalcogen or phosphorous contaminants, which could sabotage further reactions downstream for our clients.

Chemical safety shapes our practices. Amine derivatives can be volatile and, in some cases, cause skin or respiratory irritation. Technicians suit up with appropriate PPE for transfers and batch sampling. Our storage approach reflects an understanding that amines absorb atmospheric CO₂ and moisture; nitrogen-blanketed drums and sealed vials, stored in temperature-controlled environments, extend the working life of every lot.

Meeting the Needs of Innovators

A decade ago, access to specialty substituted benzylamines meant working with limited quality options, inconsistent lead times, and poorly documented batch histories. Requests from pharmaceutical and biotech labs—seeking unusual derivatives with fine-tuned reactivity—pushed us to improve on our own systems. Documentation, transparency, and deep familiarity with the material’s reaction behavior became core to how we run production.

We’ve worked with startups and established labs alike, both on single-kilo and multi-ton runs. Some partners need custom particle-size distributions for solid-phase synthesis, others request specific solvents, or prefer a certain residual solvent profile. Our reactors and isolation suites adapt to these demands. Staff chemists either consult upstream to optimize the method or work hands-on with our manufacturing crew to tune crystallization protocols. Over time, that tight integration has helped us eliminate bottlenecks and cut cycle times—benefits that reach directly into our customer’s process chemistry timelines.

Supporting Synthesis and Scale-Up

No synthesis journey stays theoretical for long. Customers typically ask for details about how our 4-Bromo-2-Fluorobenzylamine performs under both bench-scale and scale-up conditions. Early adopters shared tales of stubborn chromatography issues with other suppliers’ products; our attention to trace by-product removal and crystallinity pays off in more reproducible results. We’ve fielded technical support calls ranging from solvent selection for acylation steps to guidance on minimizing hydrodehalogenation side reactions. Each exchange feeds back into our documentation pool, tightening process predictability batch after batch.

Process safety sits high in our list of priorities. By tracking exotherms in the amination and halide exchange steps, and deploying reinforced glass-lined reactors, we manage risk effectively. Multiple temperature probes and semi-automated dose control systems, designed in-house, detect runaway scenarios before they start. This hands-on process engineering experience informs all our subsequent handling advice and shipment instructions.

Responsible and Sustainable Production

Large-scale chemical manufacture cannot ignore sustainability in the current age. Our approach to making 4-Bromo-2-Fluorobenzylamine features closed-loop solvent recovery and waste minimization at every practical step. Spent halogen and fluorine sources get processed through off-gas scrubbers and neutralizing columns to prevent environmental contamination. We’ve shifted to greener bases in amination and implemented real-time effluent pH controls after feedback from both our own analytical team and regulatory authorities.

Our staff takes pride in these improvements, which continue to evolve as regulations tighten and customer values shift. The packaging has shifted over the years too: recyclable HDPE drums replaced metal tins, and bio-based desiccants now line our sample containers. None of these changes came easy—in practice, material safety concerns required multiple validation rounds before switching suppliers and formats. Every detail cycles back to a single goal: delivering a reliable, responsibly-made product to customers who share our long-term focus.

Real-World Impact in Pharmaceutical Research

Ask a process chemist working in drug discovery which intermediates matter most, and chances are, amine-bearing aromatic compounds will rank high. 4-Bromo-2-Fluorobenzylamine sees use chiefly as a building block in medicinal chemistry. Its substitution pattern quietly influences metabolism, binding, and selectivity in a way unhalogenated benzylamines simply can’t. An N-alkylation at this scaffold might create a target molecule with improved oral availability or a lower clearance rate. Researchers working on kinase inhibitors and CNS drugs often point to the introduction of fluorinated and brominated rings as ways to dodge metabolic liability and enhance blood-brain barrier penetration.

Our technical support lines echo these challenges: project teams work under mounting time pressure to generate analogues and optimize pharmacokinetic properties before lead optimization. By supplying lot-to-lot consistent product, we help them drive decision cycles faster. Having walked the lengthy path from pilot batches to full-scale campaigns, we keep records that track not just elemental composition but also stability, residual metals, and trace solvents over storage timeframes exceeding two years.

Insights from Repeated Customer Feedback

Feedback from laboratories worldwide constantly shapes our priorities. Synthetic chemists emphasized the need for reliable product, and some pointed to specific pain points from prior suppliers—color variation suggesting decomposition, solvent residues that foiled clean NMR, and supply chain gaps right before patent deadlines. Every complaint and suggestion fed directly into our improvement projects.

Customers in the pharmaceutical sector have asked for transparency on lot origins, full Certificates of Analysis, and shipment under controlled conditions—all questions we’re able to answer confidently. We don’t just hand over a data sheet; our technical team stays available to walk through reaction sequences, share past troubleshooting experiences, and discuss scale-up risks before a project starts. Our ability to supply consistent product batches allowed one drug discovery program to transition from late-stage screening to kilogram-scale API synthesis without needing extensive re-validation.

On the academic side, throughput often matters more than scale. We keep smaller aliquots and milligram-scale vials in stock, allowing student labs and independent investigators to request only what they need. By calibrating our packaging lines for these more modest quantities, we fit changing demand and limit end-user waste.

Comparisons to Other Benzylamine Derivatives

It’s tempting to view benzylamines interchangeably, but our experience proves otherwise. Take unsubstituted benzylamine: easy to source, but too reactive and prone to over-acylation or polymerization during some syntheses. 4-Bromobenzylamine gives more selectivity, but the absence of fluorine changes both its reactivity and metabolic fate in biotransformation studies. Several customers found that 2-fluorobenzylamine lacked the versatility they needed in palladium-catalyzed cross-coupling, thanks in part to weaker handling of electron-rich intermediates.

4-Bromo-2-Fluorobenzylamine escapes these pitfalls. Its electron-withdrawing substituents stabilize certain intermediates, and the available functional points enable robust late-stage diversification. Medicinal chemistry teams, especially those adopting structure-based design, lean on this selectivity—one introduction at a critical step offers the metabolic and reactivity tweaks that platforms like FBDD (Fragment-Based Drug Discovery) demand.

Solutions to Common Challenges

Production is never free of hurdles, and over the years, we’ve faced our fair share: supply interruptions during global halogen shortages, purification quirks requiring equipment upgrades, and changing customer requests for documentation to meet audits. Solutions come down to experience, process resilience, and willingness to engage directly with every part of the manufacture and delivery chain.

Our solution to raw material variability spanned supplier partnerships, long-term contracts, and implementation of both incoming and in-process quality controls. If a batch shows deviation from pre-set chromatographic signatures, it doesn’t reach our packing room, period. Customers who’ve faced downtime from delayed or inconsistent shipments elsewhere look to these safeguards as insurance for their timelines.

On the analytical side, we expanded our QC arsenal to include chiral chromatography for projects requiring enantio-pure materials. Although this specific amine is commonly handled as a racemate, client needs continue to evolve—by staying close to the technical community, we adapt rapidly, fielding feasibility studies for custom resolutions as researchers request them.

Handling and storage represent another area demanding vigilance. Chemically, this benzylamine survives best under dry, cool, and inert conditions. Our packaging strategies underwent rigorous stress-testing, including accelerated humidity and freeze-thaw cycles, to verify real-world shelf stability. Customer feedback helped us pivot from glass ampoules to multi-layer polymer pouches, minimizing breakage and wastage during transit.

Looking Ahead

Supporting customers’ research and development projects with 4-Bromo-2-Fluorobenzylamine means staying adaptive and invested in continuous improvement. As research teams push into more complex, regulated, and sustainability-focused projects, expectations for traceability, documentation, and reliability keep rising. We support these goals by keeping our production processes transparent, our batch histories accessible, and our technical teams available for real-time questions.

We have seen firsthand the difference meticulous control and steady improvement make—not just in the purity numbers, but in the daily reality of experiments running smoother, yielding fewer surprises, and reaching endpoints faster. By combining chemistry discipline with practical feedback from our clients, our experience with 4-Bromo-2-Fluorobenzylamine becomes a resource, not just a commodity.

Conclusion

Day-to-day, our work producing 4-Bromo-2-Fluorobenzylamine links us with innovators in pharma, biotech, and more. Every batch carries the imprint of our processes, our troubleshooting history, and our commitment to customer needs. By staying grounded in real operational knowledge and flexible to evolving requirements, we supply a compound that continues to help shape new solutions in modern chemistry. We approach each synthesis not as a routine task, but as an opportunity to support discovery—batch by batch, challenge by challenge, improvement by improvement.